Het volume van chirurgische ingrepen en de impact ervan op ... - KCE
Het volume van chirurgische ingrepen en de impact ervan op ... - KCE
Het volume van chirurgische ingrepen en de impact ervan op ... - KCE
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
142 Volume Outcome <strong>KCE</strong> reports 113<br />
6.2.3 Definition of procedure<br />
A total of 169 stays are exclu<strong>de</strong>d because of cong<strong>en</strong>ital anomalies (Table 6.11).<br />
Table 6.11: CABG with/without heart valve replacem<strong>en</strong>t or repair: Exclusion<br />
of cong<strong>en</strong>ital anomalies<br />
Number Perc<strong>en</strong>t<br />
745 Bulbus cordis anomalies and anomalies of cardiac septal closure 30 17.75<br />
746 Other cong<strong>en</strong>ital anomalies of heart 129 76.33<br />
747 Other cong<strong>en</strong>ital anomalies of circulatory system 8 4.73<br />
759 Other and unspecified cong<strong>en</strong>ital anomalies 2 1.18<br />
total 169<br />
Ninety-eight per c<strong>en</strong>t of the stays (Number = 10 697) are classified in MDC 05<br />
circulatory system. The remaining 2% (Number = 265) are exclu<strong>de</strong>d from selection.<br />
As shown in Table 6.12, majority of the selected stays (99%) are in the APR-DRG<br />
CABG (165, 166) or in the APR-DRG cardiac valve (162, 163). Since there is no specific<br />
APR-DRG for the combination of the two procedures, the selection has to be ma<strong>de</strong><br />
based on the NIHDI procedure co<strong>de</strong>.<br />
Table 6.12: CABG with/without heart valve replacem<strong>en</strong>t or repair: All APR-<br />
DRG from MDC 05<br />
APR-DRG Number Perc<strong>en</strong>t<br />
166-CORONARY BYPASS W/O MALFUNCTIONING CORONARY<br />
BYPASS W/O CARDIAC CATH / 5 – P<br />
4482 41.90<br />
165-CORONARY BYPASS W/O MALFUNCTIONING CORONARY<br />
BYPASS W CARDIAC CATH / 5 - P<br />
2641 24.69<br />
163-CARDIAC VALVE PROCEDURES W/O CARDIAC 2577 24.09<br />
CATHETERIZATION / 5 - P<br />
162-CARDIAC VALVE PROCEDURES W CARDIAC 848 7.93<br />
CATHETERIZATION / 5 – P<br />
167-OTHER CARDIOTHORACIC PROCEDURES / 5 – P 76 0.71<br />
161-CARDIAC DEFIBRILLATOR IMPLANT / 5 – P 29 0.27<br />
168-MAJOR THORACIC VASCULAR PROCEDURES / 5 – P 18 0.17<br />
160-MAJOR CARDIOTHORACIC REPAIR OF HEART ANOMALY / 5 – P 8 0.07<br />
173-OTHER VASCULAR PROCEDURES / 5 – P 5 0.05<br />
174-PERCUTANEOUS CARDIOVASCULAR PROCEDURES W AMI / 5 – P 3 0.03<br />
177-CARDIAC PACEMAKER & DEFIBRILLATOR REVISION EXCEPT DEVICE<br />
REPLACEMENT / 5 – P<br />
3 0.03<br />
171-PERM CARDIAC PACEMAKER IMPLANT W/O AMI, HEART FAILURE OR<br />
SHOCK / 5 – P<br />
2 0.02<br />
175-PERCUTANEOUS CARDIOVASCULAR PROCEDURES W/O AMI / 5 – P 2 0.02<br />
180-OTHER CIRCULATORY SYSTEM PROCEDURES / 5 – P 2 0.02<br />
164-CORONARY BYPASS W MALFUNCTIONING CORONARY BYPASS<br />
GRAFT / 5 - P<br />
1 0.01<br />
total 10697 100.00<br />
Because of differ<strong>en</strong>ces in outcomes, the <strong>KCE</strong> expert group pr<strong>op</strong>osed to create three<br />
interv<strong>en</strong>tion categories:<br />
1. Isolated CABG<br />
Selection based on NIHDI co<strong>de</strong>s 229585, 229622 and 229644 (see Table 6.10 for<br />
<strong>de</strong>scription of co<strong>de</strong>s).<br />
Because of lack of information in the NIHDI co<strong>de</strong>s, it is not possible to make a<br />
distinction betwe<strong>en</strong> on and off pump CABG.<br />
2. Isolated heart valve replacem<strong>en</strong>t or repair<br />
Selection based on NIHDI co<strong>de</strong> 229600 (see Table 6.10). This interv<strong>en</strong>tion involves<br />
valve repair or valve replacem<strong>en</strong>t only.<br />
3. Combination of CABG and heart valve<br />
Selection based on co<strong>de</strong> 229526 (see Table 6.10). This interv<strong>en</strong>tion involves valve<br />
replacem<strong>en</strong>t associated with a CABG.